Report Detail
Global Infantile Spasms Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031
- RnM4652633 |
- 05 December, 2025 |
- Global |
- 85 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 157 million in 2024 and is forecast to a readjusted size of USD 199 million by 2031 with a CAGR of 3.5% during review period.
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
This report is a detailed and comprehensive analysis for global Infantile Spasms Therapeutics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Infantile Spasms Therapeutics market size and forecasts, in consumption value ($ Million), 2020-2031
Global Infantile Spasms Therapeutics market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Infantile Spasms Therapeutics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Infantile Spasms Therapeutics market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infantile Spasms Therapeutics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infantile Spasms Therapeutics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mallinckrodt, H. Lundbeck, Insys Therapeutics, Orphelia Pharma, Valerion Therapeutics, Catalyst Pharmaceuticals, Anavex Life Sciences, Retrophin, GW Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Infantile Spasms Therapeutics market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Oral
Injection
Market segment by Application
Hospital
Clinic
Other
Market segment by players, this report covers
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Infantile Spasms Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infantile Spasms Therapeutics, with revenue, gross margin, and global market share of Infantile Spasms Therapeutics from 2020 to 2025.
Chapter 3, the Infantile Spasms Therapeutics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Infantile Spasms Therapeutics market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Infantile Spasms Therapeutics.
Chapter 13, to describe Infantile Spasms Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Infantile Spasms Therapeutics by Type
- 1.3.1 Overview: Global Infantile Spasms Therapeutics Market Size by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Global Infantile Spasms Therapeutics Consumption Value Market Share by Type in 2024
- 1.3.3 Oral
- 1.3.4 Injection
- 1.4 Global Infantile Spasms Therapeutics Market by Application
- 1.4.1 Overview: Global Infantile Spasms Therapeutics Market Size by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Infantile Spasms Therapeutics Market Size & Forecast
- 1.6 Global Infantile Spasms Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Infantile Spasms Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
- 1.6.2 Global Infantile Spasms Therapeutics Market Size by Region, (2020-2031)
- 1.6.3 North America Infantile Spasms Therapeutics Market Size and Prospect (2020-2031)
- 1.6.4 Europe Infantile Spasms Therapeutics Market Size and Prospect (2020-2031)
- 1.6.5 Asia-Pacific Infantile Spasms Therapeutics Market Size and Prospect (2020-2031)
- 1.6.6 South America Infantile Spasms Therapeutics Market Size and Prospect (2020-2031)
- 1.6.7 Middle East & Africa Infantile Spasms Therapeutics Market Size and Prospect (2020-2031)
2 Company Profiles
- 2.1 Mallinckrodt
- 2.1.1 Mallinckrodt Details
- 2.1.2 Mallinckrodt Major Business
- 2.1.3 Mallinckrodt Infantile Spasms Therapeutics Product and Solutions
- 2.1.4 Mallinckrodt Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 Mallinckrodt Recent Developments and Future Plans
- 2.2 H. Lundbeck
- 2.2.1 H. Lundbeck Details
- 2.2.2 H. Lundbeck Major Business
- 2.2.3 H. Lundbeck Infantile Spasms Therapeutics Product and Solutions
- 2.2.4 H. Lundbeck Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 H. Lundbeck Recent Developments and Future Plans
- 2.3 Insys Therapeutics
- 2.3.1 Insys Therapeutics Details
- 2.3.2 Insys Therapeutics Major Business
- 2.3.3 Insys Therapeutics Infantile Spasms Therapeutics Product and Solutions
- 2.3.4 Insys Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Insys Therapeutics Recent Developments and Future Plans
- 2.4 Orphelia Pharma
- 2.4.1 Orphelia Pharma Details
- 2.4.2 Orphelia Pharma Major Business
- 2.4.3 Orphelia Pharma Infantile Spasms Therapeutics Product and Solutions
- 2.4.4 Orphelia Pharma Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Orphelia Pharma Recent Developments and Future Plans
- 2.5 Valerion Therapeutics
- 2.5.1 Valerion Therapeutics Details
- 2.5.2 Valerion Therapeutics Major Business
- 2.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Product and Solutions
- 2.5.4 Valerion Therapeutics Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.5.5 Valerion Therapeutics Recent Developments and Future Plans
- 2.6 Catalyst Pharmaceuticals
- 2.6.1 Catalyst Pharmaceuticals Details
- 2.6.2 Catalyst Pharmaceuticals Major Business
- 2.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
- 2.6.4 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.6.5 Catalyst Pharmaceuticals Recent Developments and Future Plans
- 2.7 Anavex Life Sciences
- 2.7.1 Anavex Life Sciences Details
- 2.7.2 Anavex Life Sciences Major Business
- 2.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Product and Solutions
- 2.7.4 Anavex Life Sciences Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.7.5 Anavex Life Sciences Recent Developments and Future Plans
- 2.8 Retrophin
- 2.8.1 Retrophin Details
- 2.8.2 Retrophin Major Business
- 2.8.3 Retrophin Infantile Spasms Therapeutics Product and Solutions
- 2.8.4 Retrophin Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.8.5 Retrophin Recent Developments and Future Plans
- 2.9 GW Pharmaceuticals
- 2.9.1 GW Pharmaceuticals Details
- 2.9.2 GW Pharmaceuticals Major Business
- 2.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Product and Solutions
- 2.9.4 GW Pharmaceuticals Infantile Spasms Therapeutics Revenue, Gross Margin and Market Share (2020-2025)
- 2.9.5 GW Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Infantile Spasms Therapeutics Revenue and Share by Players (2020-2025)
- 3.2 Market Share Analysis (2024)
- 3.2.1 Market Share of Infantile Spasms Therapeutics by Company Revenue
- 3.2.2 Top 3 Infantile Spasms Therapeutics Players Market Share in 2024
- 3.2.3 Top 6 Infantile Spasms Therapeutics Players Market Share in 2024
- 3.3 Infantile Spasms Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Infantile Spasms Therapeutics Market: Region Footprint
- 3.3.2 Infantile Spasms Therapeutics Market: Company Product Type Footprint
- 3.3.3 Infantile Spasms Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Infantile Spasms Therapeutics Consumption Value and Market Share by Type (2020-2025)
- 4.2 Global Infantile Spasms Therapeutics Market Forecast by Type (2026-2031)
5 Market Size Segment by Application
- 5.1 Global Infantile Spasms Therapeutics Consumption Value Market Share by Application (2020-2025)
- 5.2 Global Infantile Spasms Therapeutics Market Forecast by Application (2026-2031)
6 North America
- 6.1 North America Infantile Spasms Therapeutics Consumption Value by Type (2020-2031)
- 6.2 North America Infantile Spasms Therapeutics Market Size by Application (2020-2031)
- 6.3 North America Infantile Spasms Therapeutics Market Size by Country
- 6.3.1 North America Infantile Spasms Therapeutics Consumption Value by Country (2020-2031)
- 6.3.2 United States Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 6.3.3 Canada Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 6.3.4 Mexico Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
7 Europe
- 7.1 Europe Infantile Spasms Therapeutics Consumption Value by Type (2020-2031)
- 7.2 Europe Infantile Spasms Therapeutics Consumption Value by Application (2020-2031)
- 7.3 Europe Infantile Spasms Therapeutics Market Size by Country
- 7.3.1 Europe Infantile Spasms Therapeutics Consumption Value by Country (2020-2031)
- 7.3.2 Germany Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 7.3.3 France Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 7.3.4 United Kingdom Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 7.3.5 Russia Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 7.3.6 Italy Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
8 Asia-Pacific
- 8.1 Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Type (2020-2031)
- 8.2 Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Application (2020-2031)
- 8.3 Asia-Pacific Infantile Spasms Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Infantile Spasms Therapeutics Consumption Value by Region (2020-2031)
- 8.3.2 China Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 8.3.3 Japan Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 8.3.4 South Korea Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 8.3.5 India Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 8.3.6 Southeast Asia Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 8.3.7 Australia Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
9 South America
- 9.1 South America Infantile Spasms Therapeutics Consumption Value by Type (2020-2031)
- 9.2 South America Infantile Spasms Therapeutics Consumption Value by Application (2020-2031)
- 9.3 South America Infantile Spasms Therapeutics Market Size by Country
- 9.3.1 South America Infantile Spasms Therapeutics Consumption Value by Country (2020-2031)
- 9.3.2 Brazil Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 9.3.3 Argentina Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
10 Middle East & Africa
- 10.1 Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Type (2020-2031)
- 10.2 Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Application (2020-2031)
- 10.3 Middle East & Africa Infantile Spasms Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Infantile Spasms Therapeutics Consumption Value by Country (2020-2031)
- 10.3.2 Turkey Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 10.3.3 Saudi Arabia Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
- 10.3.4 UAE Infantile Spasms Therapeutics Market Size and Forecast (2020-2031)
11 Market Dynamics
- 11.1 Infantile Spasms Therapeutics Market Drivers
- 11.2 Infantile Spasms Therapeutics Market Restraints
- 11.3 Infantile Spasms Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Infantile Spasms Therapeutics Industry Chain
- 12.2 Infantile Spasms Therapeutics Upstream Analysis
- 12.3 Infantile Spasms Therapeutics Midstream Analysis
- 12.4 Infantile Spasms Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Infantile Spasms Therapeutics. Industry analysis & Market Report on Infantile Spasms Therapeutics is a syndicated market report, published as Global Infantile Spasms Therapeutics Market 2025 by Company, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Infantile Spasms Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
